Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shimoni

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Leukocyte Biology|June 14, 2006
Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cellsM Leiba, L Cahalon, A Shimoni, et al.
Leukemia|October 18, 2012
Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reducedA Shimoni, N Shem-Tov, A Chetrit, et al.
Bone Marrow Transplantation|July 13, 2004
Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantationA Inbal, A Lubetsky, A Shimoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationA Shimoni, J A Gajewski, M Donato, et al.
Leukemia|February 20, 2003
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemiasA Shimoni, N Kröger, A R Zander, et al.
Leukemia|May 1, 1997
Human/mouse radiation chimera generated from PBMC of B chronic lymphocytic leukemia patients with autoimmune hemolytic anemia produce anti-human red cell antibodiesH Marcus, A Shimoni, D Ergas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2009
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphomaA Avigdor, S Bulvik, I Levi, et al.
Bone Marrow Transplantation|November 21, 2007
Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphomaA Shimoni, S T Zwas, Y Oksman, et al.
Bone Marrow Transplantation|January 18, 2006
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)N Kröger, A Shimoni, T Zabelina, et al.
Cancer Research|December 22, 1999
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimeraA Shimoni, H Marcus, B Dekel, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Leukocyte Biology|June 14, 2006
Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cellsM Leiba, L Cahalon, A Shimoni, et al.
Leukemia|October 18, 2012
Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reducedA Shimoni, N Shem-Tov, A Chetrit, et al.
Bone Marrow Transplantation|July 13, 2004
Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantationA Inbal, A Lubetsky, A Shimoni, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationA Shimoni, J A Gajewski, M Donato, et al.
Leukemia|February 20, 2003
Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemiasA Shimoni, N Kröger, A R Zander, et al.
Leukemia|May 1, 1997
Human/mouse radiation chimera generated from PBMC of B chronic lymphocytic leukemia patients with autoimmune hemolytic anemia produce anti-human red cell antibodiesH Marcus, A Shimoni, D Ergas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2009
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphomaA Avigdor, S Bulvik, I Levi, et al.
Bone Marrow Transplantation|November 21, 2007
Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphomaA Shimoni, S T Zwas, Y Oksman, et al.
Bone Marrow Transplantation|January 18, 2006
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)N Kröger, A Shimoni, T Zabelina, et al.
Cancer Research|December 22, 1999
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimeraA Shimoni, H Marcus, B Dekel, et al.
Pageof 4